Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (161-170 of 365) with videos related to

Pageof 37
Sort By:
Human Vaccines|August 12, 2008
Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adultsPierre Van Damme, Gianmaria Minervini, Charles L Liss, et al.
BMC Public Health|January 25, 2022
Replacing vaccine paper package inserts: a multi-country questionnaire study on the acceptability of an electronic replacement in different target groupsMartina Bamberger, Hans De Loof, Charlotte Marstboom, et al.
Vaccine|June 30, 2016
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in menPierre Van Damme, Chris J L M Meijer, Dorothee Kieninger, et al.
Vaccine|May 26, 2007
Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-surveyHeidi Theeten, Niel Hens, Corinne Vandermeulen, et al.
BMC Pediatrics|June 15, 2010
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)Robbin Itzler, Gary Koch, David O Matson, et al.
JMIR Formative Research|April 19, 2023
The Effects of Expressing Empathy/Autonomy Support Using a COVID-19 Vaccination Chatbot: Experimental Study in a Sample of Belgian AdultsWojciech Trzebiński, Toni Claessens, Jeska Buhmann, et al.
Vaccine|March 8, 2024
The Vaccine Training Barometer: Assessing healthcare providers' confidence to answer vaccine-related questions and their training needsAurélie De Waele, Greet Hendrickx, Sara Valckx, et al.
Vaccine|April 9, 2018
Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?Kirsten Maertens, Tessa Braeckman, Stéphanie Blaizot, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 10, 2017
First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected womenSeverien Van Keer, Jade Pattyn, Wiebren A A Tjalma, et al.
Vaccine|May 16, 2025
Investigating the state of vaccine confidence among the general public and parents with children up to 13 years in Flanders (Belgium)Jade Pattyn, Nikita Hanning, Sara Valckx, et al.
Pageof 37

Showing results (161-170 of 365) with videos related to

Sort By:
Pageof 37
Human Vaccines|August 12, 2008
Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adultsPierre Van Damme, Gianmaria Minervini, Charles L Liss, et al.
BMC Public Health|January 25, 2022
Replacing vaccine paper package inserts: a multi-country questionnaire study on the acceptability of an electronic replacement in different target groupsMartina Bamberger, Hans De Loof, Charlotte Marstboom, et al.
Vaccine|June 30, 2016
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in menPierre Van Damme, Chris J L M Meijer, Dorothee Kieninger, et al.
Vaccine|May 26, 2007
Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-surveyHeidi Theeten, Niel Hens, Corinne Vandermeulen, et al.
BMC Pediatrics|June 15, 2010
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)Robbin Itzler, Gary Koch, David O Matson, et al.
JMIR Formative Research|April 19, 2023
The Effects of Expressing Empathy/Autonomy Support Using a COVID-19 Vaccination Chatbot: Experimental Study in a Sample of Belgian AdultsWojciech Trzebiński, Toni Claessens, Jeska Buhmann, et al.
Vaccine|March 8, 2024
The Vaccine Training Barometer: Assessing healthcare providers' confidence to answer vaccine-related questions and their training needsAurélie De Waele, Greet Hendrickx, Sara Valckx, et al.
Vaccine|April 9, 2018
Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?Kirsten Maertens, Tessa Braeckman, Stéphanie Blaizot, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 10, 2017
First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected womenSeverien Van Keer, Jade Pattyn, Wiebren A A Tjalma, et al.
Vaccine|May 16, 2025
Investigating the state of vaccine confidence among the general public and parents with children up to 13 years in Flanders (Belgium)Jade Pattyn, Nikita Hanning, Sara Valckx, et al.
Pageof 37